Lifecore Biomedical, Inc. · NASDAQ:LFCR
22NW Fund, LP reported a 6.74% stake in Lifecore Biomedical, Inc. (Schedule 13D/A)
Event Jun 30, 2026 · Filed Jul 2, 2026
22NW Fund, LP reported a 6.74% stake in Lifecore Biomedical, Inc., 2,712,472 shares, with active intent on Jun 30, 2026. Filed Jul 2, 2026 (Schedule 13D/A).
- Stake
- 6.74%
- Shares
- 2,712,472
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| 22NW Fund, LP | 6.74% | 2,712,472 |
| 22NW, LP | 6.74% | 2,712,472 |
| 22NW Fund GP, LLC | 6.74% | 2,712,472 |
| 22NW GP, Inc. | 6.74% | 2,712,472 |
| Aron R. English | 6.74% | 2,712,472 |
| Bryson O. Hirai-Hadley | 0% | 583 |
| Nathaniel Calloway | 0% | 0 |
Source
Related
- Lifecore Biomedical, Inc.
- 22NW Fund, LP
- Lifecore Biomedical, Inc. shareholders
- Schedule 13D/A · 22NW Fund, LP · May 29, 2025
- Schedule 13D/A · 22NW Fund, LP · Dec 26, 2024
- Schedule 13D/A · Nelson Obus · Sep 29, 2026
- Schedule 13D/A · Legion Partners Asset Management, LLC · Sep 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13D/A · Legion Partners Asset Management, LLC · Jul 2, 2026
- Form 4 · Legion Partners, L.P. I · Jun 8, 2026